Method of using a variant of VEGF receptor to treat psoriasis and to enhance wound healing

Details for Australian Patent Application No. 2002240142 (hide)

Owner REGENERON PHARMACEUTICALS, INC.

Inventors Yancopoulos, George D.; Xia, Yuping; Rudge, John S.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2002240142

PCT Pub. Number WO2002/060489

Priority 09/773,877 31.01.01 US

Filing date 28 January 2002

Wipo publication date 12 August 2002

International Classifications

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

A61K 038/17 Medicinal preparations containing peptides - from animals

A61K 038/18 Medicinal preparations containing peptides - Growth factors

C12N 015/85 Mutation or genetic engineering - for animal cells

Event Publications

20 February 2003 Application Open to Public Inspection

  Published as AU-A-2002240142

27 September 2007 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002240143-ROBOTIC AUTOSAMPLER FOR AUTOMATED ELECTROSPRAY FROM A MICROFLUIDIC CHIP

2002240141-SYSTEMIC FORMULATIONS CONTAINING BETA-CAROTENE AND DERIVATIVES THEREOF